Childhood nail psoriasis: A useful treatment with tazarotene 0.05%

Laura Diluvio, Elena Campione, Evelin J. Paternò, Cristina Mordenti, Maya El Hachem, Sergio Chimenti

Research output: Contribution to journalArticlepeer-review

Abstract

Nail psoriasis occurs in 7% to 40% of children, with a similar pattern of clinical presentation to that of adults. In 0.6% to 2.3% of the patients nail changes appear as the only sign of the disease, preceding other skin and articular involvement. No pediatric clinical trials are available yet, but considering the successful use of tazarotene for nail dystrophy therapy in adults, we chose this drug to treat a child.

Original languageEnglish
Pages (from-to)332-333
Number of pages2
JournalPediatric Dermatology
Volume24
Issue number3
DOIs
Publication statusPublished - May 2007

ASJC Scopus subject areas

  • Dermatology
  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Childhood nail psoriasis: A useful treatment with tazarotene 0.05%'. Together they form a unique fingerprint.

Cite this